查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451790

2024-2032 年按產品類型、程序類型、技術、應用和地區分類的生殖遺傳學市場報告

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023年全球生殖遺傳學市場規模達到57億美元。展望未來， IMARC Group預計到2032年市場規模將達到501億美元，2024-2032年複合年成長率（CAGR）為26.5%。大眾對遺傳性疾病的認知和理解不斷增強、預防性醫療保健的普及以及生育率的提高導致輔助生殖技術（ART）的普及，這些都是推動市場發展的一些關鍵因素。

生殖遺傳學是指專注於研究遺傳訊息及其對生殖健康和結果影響的遺傳學分支。它涉及對與生育、懷孕以及遺傳疾病從父母傳給後代相關的遺傳因素的分析和理解。生殖遺傳學涵蓋旨在識別和管理生殖過程中遺傳條件的各種技術和技術。對個人或夫婦進行特定基因突變或帶因者狀態篩檢，以評估遺傳性疾病遺傳給子女的風險。在體外受精 (IVF) 等輔助生殖技術中，PGD 涉及在胚胎植入子宮之前對胚胎進行遺傳異常分析，幫助選擇沒有特定遺傳疾病的胚胎。生殖遺傳學透過識別攜帶者狀態或個人或夫婦是否存在特定基因突變，幫助評估將遺傳性疾病傳播給後代的風險。

生殖遺傳學市場趨勢：

全球市場主要是由大眾對遺傳性疾病的認知和理解不斷增強所推動的。此外，預防性醫療保健的日益普及導致越來越多的準父母接受基因檢測，以了解未來孩子遺傳性疾病的風險，這也推動了市場的發展。隨著生育率的不斷提高，體外受精（IVF）和代孕等輔助生殖技術（ART）的採用率越來越高，這創造了一個積極的市場前景。與此一致的是，次世代定序（NGS）和高解析度微陣列等先進基因檢測技術的不斷發展正在刺激市場。此外，母親年齡的增加導致女性更容易出現染色體異常，這也為市場提供了動力。除此之外，一些國家的政府擴大支持基因研究和測試，從而促進了市場的成長。基因組定序程序的可負擔性不斷提高，進一步推動了市場的發展，導致大眾更容易獲得。促進市場發展的其他一些因素包括收入水準的上漲（特別是在發展中國家）、提供直接面對消費者的基因測試的組織的激增、個性化醫療的持續創新以及廣泛的研發（R&D）活動。

本報告回答的關鍵問題：

  • 迄今為止，全球生殖遺傳學市場表現如何，未來幾年將如何表現？
  • 全球生殖遺傳學市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生殖遺傳學市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的生殖遺傳學市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 生殖遺傳學市場上最具吸引力的產品類型是什麼？
  • 根據手術類型，市場的分類是怎樣的？
  • 生殖遺傳學市場上最具吸引力的手術類型是什麼？
  • 基於技術的市場區隔是什麼？
  • 生殖遺傳學市場上最具吸引力的技術是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 生殖遺傳學市場中最具吸引力的應用是什麼？
  • 全球生殖遺傳學市場的競爭結構如何？
  • 全球生殖遺傳學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生殖遺傳學市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 套件
    • 市場走向
    • 市場預測
  • 實驗室開發測試 (LDT)
    • 市場走向
    • 市場預測
  • 試劑及耗材
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按程序類型

  • 攜帶者篩檢
    • 市場走向
    • 市場預測
  • 產前篩檢
    • 市場走向
    • 市場預測
  • 植入前基因檢測
    • 市場走向
    • 市場預測
  • 不孕症基因檢測
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依技術

  • 下一代定序
    • 市場走向
    • 市場預測
  • 聚合酶鍊式反應
    • 市場走向
    • 市場預測
  • 原位雜合技術 (ISH/FISH)
    • 市場走向
    • 市場預測
  • 微陣列
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 非整倍體
    • 市場走向
    • 市場預測
  • 染色體結構異常
    • 市場走向
    • 市場預測
  • 單基因疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bangkok Genomics Innovation Public Company Limited
    • Centogene NV
    • Fulgent Genetics Inc.
    • Igenomix (Vitrolife Group)
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A10134

The global reproductive genetics market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.1 Billion by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global reproductive genetics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, procedure type, technology and application.

Product Type Insights:

Kits

Laboratory Developed Tests (LDT)

Reagents and Consumables

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the product type. This includes kits, laboratory developed tests (LDT), and reagents and consumables. According to the report, kits represented the largest segment.

Procedure Type Insights:

Carrier Screening

Pre-Natal Screening

Pre-Implantation Genetic Testing

Infertility Genetic Testing

A detailed breakup and analysis of the reproductive genetics market based on the procedure type has also been provided in the report. This includes carrier screening, pre-natal screening, pre-implantation genetic testing, and infertility genetic testing. According to the report, carrier screening accounted for the largest market share.

Technology Insights:

Next-Generation Sequencing

Polymerase Chain Reaction

In Situ Hybridization (ISH/FISH)

Microarray

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the technology. This includes next-generation sequencing, polymerase chain reaction, in situ hybridization (ISH/FISH), and microarray. According to the report, next-generation sequencing represented the largest segment.

Application Insights:

Aneuploidy

Structural Chromosomal Abnormality

Single Gene Disorder

Others

A detailed breakup and analysis of the reproductive genetics market based on the application has also been provided in the report. This includes aneuploidy, structural chromosomal abnormality, single gene disorder, and others. According to the report, aneuploidy accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global reproductive genetics market?
  • What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
  • What are the key regional markets?
  • Which countries represent the most attractive reproductive genetics market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the reproductive genetics market?
  • What is the breakup of the market based on the procedure type?
  • Which is the most attractive procedure type in the reproductive genetics market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the reproductive genetics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the reproductive genetics market?
  • What is the competitive structure of the global reproductive genetics market?
  • Who are the key players/companies in the global reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laboratory Developed Tests (LDT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Reagents and Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

  • 7.1 Carrier Screening
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pre-Natal Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pre-Implantation Genetic Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility Genetic Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Next-Generation Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 In Situ Hybridization (ISH/FISH)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Microarray
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Aneuploidy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Structural Chromosomal Abnormality
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Single Gene Disorder
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bangkok Genomics Innovation Public Company Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Centogene N.V.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Fulgent Genetics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Igenomix (Vitrolife Group)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Invitae Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
  • Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2023
  • Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
  • Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
  • Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Reproductive Genetics Market: Competitive Structure
  • Table 8: Global: Reproductive Genetics Market: Key Players